$10.580
+0.372 (+3.52%)At close
MNSO News
MNSO Events
Miniso Reports 25%-30% YoY GMV Growth in Q3
Miniso Group on a voluntary basis provided a business update on the latest performance of its flagship brand Miniso. The figures contained in this press release were based on the preliminary review of the company's operational data. Total GMV of Miniso Chinese mainland for the three months ended September 30, 2026 grew by 25%-30% year over year, accelerating from the first half of 2026, powered by a high-single-digit SSSG. Miniso Chinese mainland maintained its strong momentum during the National Day holidays from October 1 to October 7, 2026, with total GMV growth of 20%-25% YoY, powered by a low-single-digit SSSG. YOYO, Miniso's flagship proprietary IP, has generated GMV of over RMB1B for the first nine months of 2026 and has officially entered the global IP "One Billion Club". Since its first product launch in June 2025, YOYO has expanded into 53 countries and regions worldwide, emerging as one of the fastest Chinese original IPs to achieve large-scale global expansion. Guofu Ye, Founder, Chairman and CEO of Miniso, stated that YOYO has validated Miniso's strategic capability as a "world's leading IP operation platform", and that Miniso will empower more Chinese original IPs to scale up and accelerate in the global market. Miniso overseas markets' performance was largely in line with the company's guidance. Miniso USA delivered a GMV growth of around 20% YoY in 26Q3. Notably, it rebounded to over 30% GMV YoY growth and positive SSSG in September 2026 bolstered by new product arrivals.
Stocks Broadly Lower Following Fed Chair Speech
Stocks ended the day broadly lower following Federal Reserve Chair Kevin Warsh's speech at the Jackson Hole symposium. In his first major speech since taking the chair in May, Warsh warned that inflation has not meaningfully slowed, signaling that policymakers may have "work to do" to bring inflation back down to the Fed's 2% target.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Advent and Stripe are no longer pursuing a $50B deal for PayPal,Marvellreportedand provided guidance for Q3Gapprovided a "beat and raise" report for Q2Element Solutionsand Solstice Advanced Materialsmutually agreed toGE Vernovanamed Rivian's2. WALL STREET CALLS:Modernato Buy at Argus after FDA approval for updated Covid vaccinesWorkdayto Equalweight at Capital OneTeraWulfwith an Outperform at William BlairEvolution Petroleumto Outperform at NorthlandAllstateto Hold at Argus3. AROUND THE WEB:The U.S. appeals court sided with Nevada regulators, allowing the state to treat sports prediction markets like unlicensed sportsbooks, while sending Kalshi's election contracts back for further consideration, Bloomberg Law reportsChevronappears positioned to invest billions of dollars and expand its Venezuela footprint, while Halliburtoncould benefit from increased oilfield services activity, WSJ reportsAnthropic discussed buying AI chip startup MatX for about $7B, but talks are no longer active, Reuters saysKimberly-Clarkhas asked EU regulators permission for its proposed $40B takeover of Kenvue, Reuters reportsSoftBankis in talks to buy a majority stake in humanoid robot maker 1X at a $6B valuation, The Information says4. MOVERS:Elasticadvanced after, providing guidance for Q2, and raising its outlook for FY27PagerDutygained afterand raising its guidance for FY27N-ablewas higher after announcing a $50M increase to itsRubrikfell afterand raising its guidance for FY27BioNTechwas lower in New York after announcing it will terminate its5. EARNINGS/GUIDANCE:Chase, with EPS beating consensusFiscalNoteprovidedMiniso, with CEO Guofu Ye "pleased to see that MINISO Chinese mainland delivered a standout performance"Koss Corp., with EPS and revenue higher year-over-yearAffirmand provided guidance for Q1 and FY27INDEXES:The Dow fell 9.45, or 0.02%, to 53,559.99, the Nasdaq lost 138.93, or 0.52%, to 26,402.42, and the S&P 500 declined 19.23, or 0.25%, to 7,711.76.
Major Averages Rise After Fed Chair's Speech
The major averages were higher near noon after Federal Reserve Chair Kevin Warsh's speech at the Jackson Hole symposium. In his first major speech since taking the chair in May, Warsh warned that inflation has not meaningfully slowed, signaling that policymakers may have "work to do" to bring inflation back down to the Fed's 2% target.The Treasury market remains a risk as long-term yields have risen sharply in recent weeks, with the 30-year yield near levels last seen in 2007. Treasury Secretary Scott Bessent's expanded bond-buyback program has attempted to ease pressure at the long end of the curve, but investors remain concerned about inflation, government borrowing and the fiscal outlook.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Advent and Stripe are no longer pursuing a $50B deal for PayPal,Marvellreportedand provided guidance for Q3Gapprovided afor Q2Element Solutionsand Solstice Advanced Materialsmutually agreed toGE Vernovanamed Rivian's2. WALL STREET CALLS:Modernato Buy at Argus after FDA approval for updated Covid vaccinesWorkdayto Equalweight at Capital OneTeraWulfwith an Outperform at William BlairEvolution Petroleumto Outperform at NorthlandAllstateto Hold at Argus3. AROUND THE WEB:Chevronappears positioned to invest billions of dollars and expand its Venezuela footprint, with a potential addition of two heavy-oil fields, while Halliburtoncould benefit from increased oilfield services activity, WSJ reportsAnthropic discussed buying AI chip startup MatX for about $7B, but talks are no longer active, Reuters saysKimberly-Clarkhas asked EU regulators permission for its proposed $40B takeover of Kenvue, Reuters reportsSoftBankis in talks to buy a majority stake in humanoid robot maker 1X at a $6B valuation, The Information saysYouTubeand TikTok are yet to publicly acknowledge Meta'sproposed changes under its AG settlement, NY Times reports4. MOVERS:Elasticincreases after, providing guidance for Q2, and raising its outlook for FY27PagerDutygains afterand raising its guidance for FY27N-ablehigher after announcing a $50M increase to itsRubrikfalls afterand raising its guidance for FY27BioNTechlower in New York after announcing it will terminate itsof a cancer vaccine5. EARNINGS/GUIDANCE:Chasewith EPS beating consensusFiscalNoteMiniso, with CEO Guofu Ye "pleased to see that MINISO Chinese mainland delivered a standout performance"Koss Corp., with EPS and revenue higher year-over-yearAffirmand provided guidance for Q1 and FY27INDEXES:Near midday, the Dow was up 94.13, or 0.18%, to 53,663.57, the Nasdaq was up 51.28, or 0.19%, to 26,592.63, and the S&P 500 was up 16.06, or 0.21%, to 7,747.05.
U.S. Stock Futures Slightly Lower, Focus on Fed Policy Speech
Stock futures are slightly lower Friday after Thursday's AI-driven rally as attention turns to Federal Reserve Chair Kevin Warsh's first major policy speech at the Jackson Hole symposium. Investors are looking for clarity on the Fed's reaction to inflation that remains above its 2% target, a softer labor market and unusually high long-term Treasury yields. Markets are currently pricing about a 36% probability of a September rate hike.The Treasury market remains a major risk. Long-term yields have risen sharply in recent weeks, with the 30-year yield near levels last seen in 2007. Treasury Secretary Scott Bessent's expanded bond-buyback program has attempted to ease pressure at the long end of the curve, but investors remain concerned about inflation, government borrowing and the fiscal outlook.In pre-market trading, S&P 500 futures rose 0.08%, Nasdaq futures fell 0.13% and Dow futures rose 0.15%.Check out this morning's top movers from around Wall Street, compiled by The Fly.UP AFTER EARNINGS -Elasticup 24%Gapup 18%Affirmup 12%DOWN AFTER EARNINGS -Marvelldown 7%Minisodown 4%Rubrikdown 4%Autodeskdown 3%Chageedown 3%LOWER -PayPaldown 14% after Bloomberga consortium of Advent and Stripe are abandoning a pursuit of the companyCytokinetics (CYTK) down 2% after announcing the primary results from ACACIA-HCM, the Phase 3 clinical trial of aficamten in patients with symptomatic non-obstructive hypertrophic cardiomyopathy
MINISO Reports Q2 Revenue of RMB 5.81B
Reports Q2 revenue RMB 5.81B, consensus RMB 5.79B. Guofu Ye, founder, chairman and CEO of Miniso, commented, "Despite a challenging consumer environment in the domestic market during 26H1, we are pleased to see that MINISO Chinese mainland delivered a standout performance, with revenue growing 26.2% YoY, our fastest first-half growth rate in the past three years, driven by mid-single-digit SSSG. MINISO overseas markets grew 14.9% YoY, while TOP TOY grew 32.7% YoY."
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.




